Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • News

Editor-in-Chief: Giuseppe Leone | Italy

3.3
CiteScore 2024
3.3
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Multiple bone and joint disease in a sickle cell anaemia patient: a case report

    John Ayodele Olaniyi, Adekunle E Alagbe, Olutoogun O Toluwalase, Olorunsogo E Busari
    e2012023
    2012-05-03
    https://doi.org/10.4084/mjhid.2012.023
    1204
    PDF: 706
    HTML: 1696
  • THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE

    Lucrezia Laterza, Gianenrico Rizzatti, Eleonora Gaetani, Patrizia Chiusolo, Antonio Gasbarrini
    e2016025
    2016-05-01
    https://doi.org/10.4084/mjhid.2016.025
    6179
    PDF: 2048
    HTML: 13969
    Untitled: 184
    figure: 159
  • GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA

    Pouyan Kheirkhah, Ana M. Avila-Rodriguez, Bartlomiej Radzik, Carlos Murga-Zamalloa
    e2021067
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.067
    1164
    PDF: 572
    HTML: 201
  • PREVENTION AND TREATMENT OF HEPATITIS VIRUS INFECTION IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS

    Suparno Chakrabarti, Somnath Mukherjee
    e2009017
    2009-12-10
    https://doi.org/10.4084/mjhid.2009.017
    747
    PDF: 541
    HTML: 2442
  • IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?

    Federica Sorà, Patrizia Chiusolo, Francesco autore, Sabrina Giammarco, luca laurenti, elisabetta metafuni, idanna innocenti, eugenio galli, andrea bacigalupo, simona sica
    e2021062
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.062
    1154
    PDF: 439
    HTML: 140
  • TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi
    e2023038
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.038
    1988
    PDF: 1602
    HTML: 345
  • Common parasite with uncommon associations

    Sonal Jain, Jasmita Dass, Monica Sharma, Seema Tyagi
    e2011015
    2011-03-29
    https://doi.org/10.4084/mjhid.2011.015
    1468
    PDF: 647
    HTML: 1824
  • EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES

    Pietro Tralongo, Arianna Bakacs, Luigi Maria Larocca
    e2024042
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.042
    4001
    PDF: 1534
    HTML: 841
  • AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS

    Pavankumar Tandra, Jairam Krishnamurthy, Vijaya Bhatt, Kam Newman, James O Armitage, Mojtaba Akhtari
    e2013068
    2013-11-04
    https://doi.org/10.4084/mjhid.2013.068
    2115
    PDF: 1160
    HTML: 3685
  • IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?

    Giuseppe Gritti, Chiara Pavoni, Alessandro Rambaldi
    e2017010
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.010
    3303
    PDF: 1249
    HTML: 2193
    Fi.1 Gritti.Rambaldi: 185
  • Morphologic confounders and CD19 negativity in a case of hairy cell leukemia.

    Pulkit Rastogi, Sreejesh Sreedharanunni, Uday Yanamandra, Man Updesh Singh Sachdeva, Neelam Varma
    e2017033
    2017-05-01
    https://doi.org/10.4084/mjhid.2017.033
    2204
    PDF: 797
    HTML: 1200
  • TYROSINE KINASE INHIBITORS AND INTERFERON

    Maria Dimou, Panagiotis Panagiotidis
    e2014006
    2014-01-02
    https://doi.org/10.4084/mjhid.2014.006
    2798
    PDF: 1391
    HTML: 3038
    Cover Letter: 182
  • Concurrent diagnosis of acute myeloid leukemia and symptomatic COVID-19 infection: a case report successfully treated with Azacitidine-Venetoclax combination

    Daniela Taurino, Marco Frigeni, Anna Grassi, Gianluca Cavallaro, Silvia Salmoiraghi, Orietta Spinelli, Alessandro Rambaldi, Federico Lussana
    e2021057
    2021-08-28
    https://doi.org/10.4084/MJHID.2021.057
    1110
    PDF: 461
    HTML: 156
  • GENE THERAPY IN THALASSEMIA AND HEMOGLOBINOPATHIES

    Laura Breda, Roberto Gambari, Stefano Rivella
    e2009008
    2009-11-16
    1227
    PDF: 411
    HTML: 2868
  • ATRA induced Reactive Hemophagocytosis: A Case Report

    Monica Sharma, Sanjeev Kumar Sharma, Jasmita Dass, Seema Tyagi
    e2011034
    2011-09-08
    https://doi.org/10.4084/mjhid.2011.034
    1177
    PDF: 555
    HTML: 2841
    ATRA induced Reactive Hemophagocytosis: A Case Report: 178
  • PROGNOSTIC IMPACT OF IMMUNOHISTOCHEMICAL P53 EXPRESSION IN BONE MARROW BIOPSY IN HIGHER RISK MDS: A PILOT STUDY

    Alfredo Molteni, Emanuele Ravano, Marta Riva, Michele Nichelatti, Laura Bandiera, Lara Crucitti, Mauro Truini, Roberto Cairoli
    e2019015
    2019-02-26
    https://doi.org/10.4084/mjhid.2019.015
    1762
    PDF: 949
    HTML: 290
  • FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.

    Andrea Gallamini, Anna Borra
    e2017029
    2017-04-15
    https://doi.org/10.4084/mjhid.2017.029
    3245
    PDF: 1208
    HTML: 2176
  • THROMBOCYTOPENIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - STILL AN UNSOLVED PROBLEM

    May Basood, Howard S. Oster, Moshe Mittelman
    e2018046
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.046
    2966
    PDF: 1334
    HTML: 513
  • Long-term persistence of dysplastic features in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide

    Enrico Santinelli, Maria Rosaria Pascale, Luca Guarnera, Arianna Savi, Flavia Mallegni, Carmelo Gurnari, Luca Maurillo, Maria Teresa Voso, Susanna Fenu
    e2025038
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.038
    943
    PDF: 688
    HTML: 75
  • BENDAMUSTINE AND RITUXIMAB AS FIRST LINE TREATMENT IN SPLENIC MARGINAL ZONE LYMPHOMAS of ELDERLY PATIENTS.

    Roberto Castelli
    e2016030
    2016-07-01
    https://doi.org/10.4084/mjhid.2016.030
    4257
    PDF: 951
    HTML: 1644
  • HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS

    Mazyar Shadman, Joachim Deeg
    e2014056
    2014-09-01
    https://doi.org/10.4084/mjhid.2014.056
    1937
    PDF: 737
    HTML: 3101
  • Community-acquired Carbapenem-resistant Escherichia coli Bacteremia Complicated by c: A Case Report

    Yu Chen, Jin Zhang, wenqiang kong
    e2026005
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.005
    463
    PDF: 331
    HTML: 75
  • ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA

    Luca Laurenti, Michela Tarnani, Patrizia Chiusolo, Federica Sorà, Simona Sica
    e2010026
    2010-08-31
    https://doi.org/10.4084/mjhid.2010.026
    1316
    PDF: 733
    HTML: 931
  • HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation

    Anna Maria Testi
    e2022038
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.038
    1043
    PDF: 716
    HTML: 188
  • ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES

    Daniel Olson, Abraham Tareq Yacoub, Gelenis Domingo, John Norman Greene
    e2014068
    2014-08-28
    https://doi.org/10.4084/mjhid.2014.068
    1778
    PDF: 691
    HTML: 2083
    Untitled: 192
    Untitled: 139
    Untitled: 152
    Untitled: 141
    Untitled: 145
    Untitled: 161
    Untitled: 168
  • RECENT ADVANCES IN THE 5Q- SYNDROME

    Andrea Pellagatti, Jacqueline Boultwood
    e2015037
    2015-05-20
    https://doi.org/10.4084/mjhid.2015.037
    2687
    PDF: 1755
    HTML: 3635
    Pellagatti Fig 1: 189
    Pellagatti Fig. 2: 188
  • USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS

    Paola Mancino, Katia Falasca, Claudio Ucciferri, Eligio Pizzigallo, Jacopo Vecchiet
    e2010003
    2010-03-26
    https://doi.org/10.4084/mjhid.2010.003
    1030
    PDF: 491
    HTML: 804
  • Multiple Myeloma and Paget’s disease with abnormal skull lesions and intracranial hypertension

    Tommaso Caravita, Agostina Siniscalchi
    e2112068
    2012-11-04
    https://doi.org/10.4084/mjhid.2012.068
    1040
    PDF: 625
    HTML: 10803
  • CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment

    Michele Malagola, Raffaella Greco, Stella Santarone, Anna Paola Iori, Luisa Quatrocchi, Walter Barberi, Bruzzese Antonella, Salvatore Leotta, Alessandra Carotti, Antonio Pierini, Simon Bernardi, Enrico Morello, Nicola Polverelli, Alessandro Turra, Federica Cattina, Lisa Gandolfi, Benedetta Rambaldi, Francesca Lorentino, Francesca Serio, Annalisa Natale, Giuseppe Milone, Andrea Velardi, Robin Foà, Fabio Ciceri, Domenico Russo, Jacopo Peccatori
    e2019048
    2019-08-29
    https://doi.org/10.4084/mjhid.2019.048
    1864
    PDF: 1127
    HTML: 249
  • TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.

    Aditi Singh, MD, Ishaq Asghar, MD, Laura Kohler, DO, Hosam Hakim, MD, Daniel Snower, MD, Daniel Lebovic, MD
    e2022018
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.018
    1594
    PDF: 707
    HTML: 458
  • CURRENT STRATEGIES FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

    Juliana Maria Camargos Rocha, Sandra Guerra Xavier, Marcelo Eduardo Lima Souza, Juliana Godoy Assumpção, Mitiko Murao, Benigna Maria Oliveira
    e2016024
    2016-04-10
    https://doi.org/10.4084/mjhid.2016.024
    4464
    PDF: 1295
    HTML: 4592
  • CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE

    omar ziad alrawi, fawzi abdel-latif abdel-rahman, rula alnajjar, husam abujazar, mourad salam, mustafa saad
    e2015049
    2015-08-25
    https://doi.org/10.4084/mjhid.2015.049
    1505
    PDF: 856
    HTML: 964
    figures: 154
    table 1: 163
    table2: 161
    table3: 162
  • INFECTIONS IN THALASSEMIA AND HEMOGLOBINOPATHIES

    Bianca Maria Ricerca, Arturo Di Girolamo, Deborah Rund
    e2009028
    2009-12-28
    1040
    PDF: 593
    HTML: 4267
  • A case of severe gastrointestinal toxicity after allogeneic hematopoietic stem cell transplantation: can we improve the evaluation of the “gut fitness“ ?

    Gabriele Magliano, Enrico Morello, Mirko Farina, Vera Radici, Marco Galli, giulia brambilla, Michele Malagola, Domenico Russo, Daniele Avenoso
    e2025054
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.054
    602
    PDF: 438
    HTML: 46
  • Acute Hemolytic Anemia Following Rasburicase in a Very Late Post-Transplant Relapse of Acute Myeloid Leukemia

    Gianluca Cavallaro, Federico Lussana, Marco Frigeni, Maria Caterina Micò, Alessandra Algarotti, Anna Grassi, Orietta Spinelli, Chiara Pavoni, Elena Oldani, Alessandro Rambaldi
    e2026003
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.003
    518
    PDF: 356
    Html: 82
  • ACTIVIN RECEPTOR LIGAND FOR THR TREATMENT OF BETA-THALASSEMIA: a SERENDIPITOUS DISCOVERY

    Irene Motta, Valentina Brancaleoni, Isabella Nava, Paola Delbini, Lorena Duca
    e2020075
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.075
    1433
    PDF: 1358
    HTML: 468
  • ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN THE TREATMENT OF CHRONIC LYMPHOCITIC LEUKEMIA : WHY AND WHEN ?

    Maria L. Delioukina, Stephen J. Forman
    e2010018
    2010-06-30
    https://doi.org/10.4084/mjhid.2010.018
    1193
    PDF: 766
    HTML: 526
  • OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION FOLLOWING REDUCED-INTENSITY CONDITIONINIG REGIMEN IN PATIENTS WITH IDIOPATHIC MYELOFIBROSIS: THE G.I.T.M.O. EXPERIENCE AND REVIEW OF THE LITERATURE

    Francesca Patriarca, Andrea Bacigalupo, Alessandra Sperotto, Miriam Isola, Maria Teresa Van Lint, Anna Paola Iori, Paolo Di Bartolomeo, Maurizio Musso, Pietro Pioltelli, Giuseppe Visani, Pasquale Iacopino, Renato Fanin, Alberto Bosi
    e2010010
    2010-05-07
    https://doi.org/10.4084/mjhid.2010.010
    1453
    PDF: 745
    HTML: 750
  • Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review

    Susmitha Apuri, Kristin Carlin, Edward Bass, Phuong Thuy Nguyen, John Norman Greene
    e2014014
    2014-02-18
    https://doi.org/10.4084/mjhid.2014.014
    3464
    PDF: 1442
    HTML: 4296
    CoverLetter: 167
    Figure1: 176
  • Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy

    Antonella Vaccarino, Irene Dogliotti, Fabio Marletto, Andrea Demarchi, Mario Bazzan
    e2016050
    2016-10-20
    https://doi.org/10.4084/mjhid.2016.050
    2719
    PDF: 729
    HTML: 1243
    Blood Count trend before and during lenalidomide treatment: 154
    Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 169
  • ROLE OF BIOMARKERS AS PREDICTORS OF INFECTION AND DEATH IN NEUTROPENIC FEBRILE PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION.

    Karim Massaro, Silvia F Costa
    e2015059
    2015-10-15
    https://doi.org/10.4084/mjhid.2015.059
    2015
    PDF: 954
    HTML: 1689
  • Clinical and Prognostic Features in a Young Adult Patient with de novo Myelodysplastic Syndrome presenting t(11;16) (q23; q24)

    Viviane Lamim Lovatel, Luize Otero, Ercole Pietro Orlando, Claudia Diniz, Filipe Vicente dos Santos-Bueno, Bruno Almeida Lopes, Elaiza Almeida Antônio de Kós, Monica Kopischitz Praxedes Lusis, Eliana Abdelhay, Teresa de Souza Fernandez
    e2022013
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.013
    1046
    PDF: 511
    HTML: 208
  • CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA

    Livio Pagano, Morena Caira, Caterina Giovanna Valentini, Luana Fianchi
    e2009030
    https://doi.org/10.4084/mjhid.2009.030
    1230
    PDF: 587
    HTML: 3059
  • THALASSAEMIA INTERMEDIA : AN UPDATE

    Ali Taher, Khaled M. Musallam, Maria Domenica Cappellini
    e2009004
    2009-08-17
    1029
    PDF: 425
    HTML: 9414
  • Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin

    Caterina Giovanna Valentini, Valentina Bozzoli, Anna Rita Larici, Luigi Maria Larocca, Giovanni Delogu, Giuseppe Leone, Livio Pagano
    e2012040
    2012-06-18
    https://doi.org/10.4084/mjhid.2012.040
    1802
    PDF: 620
    HTML: 19227
  • As a Rare Site of Invasive Fungal Infection, Chronic Granulomatous Aspergillus Synovitis: A Case Report

    Aylin Canbolat Ayhan, Korhan ozkan, Cetin Timur, Birol Aktaş, Ayse Bahar Ceyran
    e2013043
    2013-06-06
    https://doi.org/10.4084/mjhid.2013.043
    1666
    PDF: 603
    HTML: 1499
    Figure 1: MRI demonstrating Aspergillus synovitis: 166
    Figure 2:MRI demonstrating Aspergillus synovitis: 163
  • Single agent lenalidomide activity in multiple myeloma relapse evidenced uniquely by CT/PET

    Alessandro Gozzetti, Vania Rossi, Alfonso Cerase, Giulia Papini, Marzia Defina, Monica Bocchia
    e2012041
    2012-06-19
    https://doi.org/10.4084/mjhid.2012.041
    1067
    PDF: 629
    HTML: 590
  • Late-onset hepatic veno-occlusive disease after allografting: report of two cases with atypical clinical features successfully treated with defibrotide.

    Alessia Castellino, Stefano Guidi, Chiara Dellacasa, Antonella Gozzini, Irene Donnini, Chiara Nozzoli, Sara Manetta, Semra Aydin, Luisa Giaccone, Moreno Festuccia, Lucia Brunello, Enrico Maffini, Benedetto Bruno, Ezio David, Alessandro Busca
    e2018001
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.001
    4015
    PDF: 968
    HTML: 976
  • POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.

    Sinem Başak Tan Öksüz, Güldane Cengiz Seval, Klara Dalva, Selami Koçak Toprak
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.028
    564
    PDF: 286
    Suppl. Files: 104
    HTML: 96
  • PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations

    Michele Bibas
    e2024007
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.007
    3430
    PDF: 2345
    HTML: 1411
101 - 150 of 459 items << < 1 2 3 4 5 6 7 8 9 10 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy